Not all shockwave therapy systems are built the same. Understanding how electromagnetic, electrohydraulic, and piezoelectric technologies differ — and what those differences mean for your clinic — is the foundation of a sound capital equipment decision.
How Each Technology Generates a Shockwave
All three focused shockwave technologies convert electrical energy into a high-pressure acoustic wave, but the mechanism — and the clinical and operational consequences — varies significantly between them.
Electromagnetic (EM)
An electrical current passes through a coil, creating a rapidly changing magnetic field that repels a metallic membrane. The resulting pressure pulse is propagated through a water medium and focused by an acoustic lens. The energy profile is highly consistent from pulse to pulse, and the focal zone can be positioned at controllable depths. Applicator components are robust, with typical lifespans measured in hundreds of thousands to over one million shocks before service is required. This category includes widely recognized platforms such as Storz Medical’s Duolith line, Enraf-Nonius’s Shockmaster series, BTL Industries’ BTL-6000 SWT, Zimmer MedizinSystems’ enPuls Pro, and the Infinium FOCUS™.
Electrohydraulic (EH)
A high-voltage spark discharge between two electrodes vaporizes a small volume of water, generating a spherical pressure wave that is reflected and focused by an ellipsoidal reflector. EH systems can produce very high peak pressures and large focal volumes. However, electrode erosion means consumable replacement is frequent, energy output can vary between electrode sets, and per-treatment consumable costs are meaningfully higher than EM alternatives. EH technology has historically been associated with brands such as Dornier’s Aries, Compact Sigma, and Epos Ultra platforms, early-generation Storz Medical electrohydraulic units, and TRT (Tissue Regeneration Technologies) Softwave/OrthoGold 100 devices — many of which trace their lineage to lithotripsy-derived shockwave engineering.
Piezoelectric (PZT)
Hundreds of piezoelectric crystals arranged on a concave dish fire simultaneously, producing a tightly focused wave with a very small focal zone. The precise focus can be advantageous for small, well-localized targets, but the shallow effective depth and lower energy output limit utility across the broader range of musculoskeletal indications. Crystal arrays also represent a significant repair cost if damaged. Recognized names in this category include Richard Wolf’s PiezoWave2 series and MTS Europe’s Piezoson platforms.
A Related but Distinct Category: Radial and Ballistic Pressure Wave Systems
Buyers researching this market will also encounter devices marketed as “shockwave” that use a fundamentally different, unfocused mechanism — typically pneumatic or ballistic generation of a radial pressure wave rather than a focused acoustic wave. EMS’s Swiss DolorClast and DJO Chattanooga’s shockwave line are commonly cited examples of this radial/ballistic category. These systems dissipate energy across superficial tissue rather than concentrating it at a controlled depth, and they are not directly comparable to the focused EM, EH, and PZT technologies covered in this guide. Confirm with any manufacturer whether a device is focused or radial before comparing it against the platforms discussed here.
These brand associations reflect general market positioning by technology type and are provided for orientation only — buyers should always confirm the specific mechanism, specifications, and included protocols for any model under evaluation directly with the manufacturer.
Clinical Performance Comparison
For B2B buyers evaluating which platform best serves a multi-indication clinical environment, the table below summarizes the key performance dimensions across all three focused shockwave technologies.
| Dimension | Electromagnetic | Electrohydraulic | Piezoelectric |
|---|---|---|---|
| Penetration Depth | Deep (up to 10–12 cm) | Deep, large focal volume | Shallow to moderate |
| Energy Consistency | High — coil/membrane output is stable | Variable — degrades with electrode wear | High — but lower absolute energy |
| Focal Zone Control | Precise; adjustable depth via water column | Fixed geometry; large focal area | Very tight; limited repositioning |
| Patient Comfort | Controlled energy ramp; generally well tolerated | High peak pressure; can be more painful | Typically comfortable at lower energies |
| Indication Breadth | Broad — superficial and deep tissue | Broad but less precise targeting | Narrower — best for small, superficial targets |
| Gel Requirement | Gel-free (water-based coupling) | Water bath or gel required | Gel or water coupling required |
| Representative Brands | Infinium FOCUS™, Storz Medical Duolith, Enraf-Nonius Shockmaster, BTL Industries BTL-6000 SWT, Zimmer enPuls Pro | Dornier Aries/Compact Sigma/Epos Ultra, legacy Storz Medical EH units, TRT Softwave/OrthoGold 100 | Richard Wolf PiezoWave2, MTS Piezoson |
Operational and Ownership Cost Considerations
Clinical performance is only part of the equation. For practice managers and procurement teams, total cost of ownership — including consumables, maintenance intervals, and downtime risk — often determines which technology delivers the best return over a three-to-five-year horizon.
Consumable Cost Per Treatment
Electrohydraulic systems require periodic electrode replacement as the spark gap erodes. Depending on utilization volume, this can represent a meaningful recurring cost and introduces variability in energy output as electrodes age. Electromagnetic systems, by contrast, use a coil-and-membrane design with substantially longer service intervals — reducing both consumable spend and the administrative burden of tracking replacement schedules. Piezoelectric crystal arrays are durable under normal use but carry high repair costs if the array is damaged.
Downtime and Service Risk
Any technology that requires frequent consumable swaps introduces scheduling risk. If an electrode set fails mid-week, patient appointments must be rescheduled. Electromagnetic platforms with long-life applicators reduce this exposure and support more predictable clinic scheduling.
Revenue Model Fit
Focused shockwave therapy is widely offered as a cash-pay service, making per-treatment margin a direct driver of practice profitability. Lower consumable costs per session translate directly to higher retained margin. Clinics running high weekly treatment volumes will see the consumable cost differential compound significantly over a device’s operational life.
Typical Equipment Investment Range
Upfront capital cost varies by technology, applicator configuration, and included clinical software — but understanding the general investment tier for each category helps frame the total cost of ownership conversation. The figures below are illustrative market ranges only and should be confirmed directly with manufacturers during a formal quote process.
| Technology | Illustrative One-Time Investment Range | Primary Cost Drivers |
|---|---|---|
| Electromagnetic | Mid to upper mid-range | Applicator design, number of included protocols, touchscreen/software platform, warranty terms |
| Electrohydraulic | Lower to mid-range upfront, higher lifetime cost | Lower initial unit price offset by recurring electrode consumable spend over the device’s service life |
| Piezoelectric | Mid to upper range | Crystal array density, handpiece precision engineering, narrower indication scope relative to price |
Because these are broad category ranges rather than fixed price points, buyers should request itemized quotes that separate the base unit, applicator/handpiece, software licensing, training, warranty, and any financing terms. This makes it possible to compare the true one-time investment against the ongoing consumable and service costs outlined above — rather than evaluating sticker price in isolation.
Buyer Decision Criteria: What to Evaluate Before You Purchase
Use the following checklist when comparing focused shockwave platforms from any manufacturer — whether Storz Medical, BTL Industries, DJO Chattanooga, EMS, Dornier, Zimmer, TRT, Richard Wolf, or the Infinium FOCUS™. These criteria reflect the questions most frequently raised by clinical directors, practice owners, and procurement teams during capital equipment evaluations.
- Is the device a focused shockwave system, or an unfocused/radial pressure wave device?
- What is the effective focal depth range, and does it cover your primary patient indications?
- How consistent is energy output across the applicator’s service life?
- What are the consumable components, and what is the realistic cost per treatment at your expected volume?
- What is the rated lifespan of the applicator and key internal components?
- Does the system require gel, a water bath, or neither for acoustic coupling?
- How many clinical protocols or condition-specific presets does the system include?
- What is the touchscreen or interface learning curve for clinical staff?
- What warranty, service contract, and technical support options are available?
- Does the manufacturer provide ROI modeling or clinical utilization guidance?
- Is the device compact enough for your available clinical space?
Technology Summary: Which Platform Fits Which Clinic?
Best Fit for Electromagnetic
Multi-indication practices — orthopedics, sports medicine, physiotherapy, urology, and rehabilitation — that need reliable deep-tissue penetration, broad protocol coverage, low consumable overhead, and a platform that supports a high-margin cash-pay service model. The combination of long applicator life, consistent output, and adjustable focal depth makes EM the most operationally practical choice for busy clinical environments. Alongside established names like Storz Medical, Enraf-Nonius, BTL Industries’ BTL-6000 SWT, and Zimmer’s enPuls Pro, the Infinium FOCUS™ competes directly in this category.
When to Consider Alternatives
Electrohydraulic systems — historically associated with brands such as Dornier’s Epos Ultra and Aries lines, or TRT’s Softwave/OrthoGold 100 — may be considered in research or lithotripsy-adjacent settings where very large focal volumes are clinically appropriate and electrode replacement is budgeted into the service model. Piezoelectric platforms, such as Richard Wolf’s PiezoWave2 and MTS’s Piezoson, may suit highly specialized applications requiring an extremely tight focal zone at shallow depths, though their narrower indication range limits revenue diversification for most outpatient practices. Radial/ballistic devices like EMS’s Swiss DolorClast or DJO Chattanooga’s shockwave line remain unfocused pressure wave systems best suited to superficial, generalized tissue applications rather than the depth-controlled protocols offered by focused shockwave platforms.
